Page last updated: 2024-11-01

nomifensine and Empty Sella Syndrome

nomifensine has been researched along with Empty Sella Syndrome in 1 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbarino, A1
De Marinis, L1
Mancini, A1
D'Amico, C1
Sambo, P1
Passeri, M1
Anile, C1
Maira, G1

Other Studies

1 other study available for nomifensine and Empty Sella Syndrome

ArticleYear
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
    Hormone research, 1987, Volume: 27, Issue:3

    Topics: Adult; Empty Sella Syndrome; Female; Humans; Intracranial Pressure; Metoclopramide; Nomifensine; Obe

1987